“A shared culture is the key to any successful partnership – Medidata’s commitment to integrity and to putting the client at the center of its work aligns perfectly with palleos’ values.”

"We didn’t go shopping, we knew we wanted to use Medidata and it was a matter of working to find the right study build model to fit our business needs.”

"When compared with traditional cardiovascular trials that engage hundreds or thousands of sites, this technology allowed us to enroll 15,000 participants from 40 centers. We think this infrastructure and approach will facilitate studies that can be direct-to-patient, easier for patients and investigators, and faster to completion."

"Since Medidata developed the web services on the open operational data model (ODM) standard, Spaulding can rapidly apply integration designs to other studies and sponsors."

“It is to everyone’s advantage to [use Medidata’s] unified platform so that there is one login. There is one way that people are accessing all the things they need to do with their data. If we’re thinking of patients and sites first, we have to think about that value…[so] they’re …

“Our partnership with Medidata has enabled us to offer top-notch service to sponsors. In the last decade, we’ve embraced the latest Rave EDC technology, including eCOA/ePRO via the Patient Cloud and Rave Coder. We’ve successfully configured intricate study designs, from early-phase oncology with numerous protocol changes to rare disease studies …

“Visibility into patient reporting helps us mitigate protocol compliance issues early in the study rather than later, when it’s harder.”

“Medidata is a valued and trusted partner. We use a range of their solutions which have allowed us to manage various unique and complex study requirements without having to use custom programming. This has ensured consistent and efficient trial execution.”

"Medidata operational support has made us more efficient by enabling us to reallocate resources to focus on what's most important - clinical research."

"We eliminated double data entry at the medical institution and were able to improve efficiency in clinical trial data capture."

“We have a strong partnership that goes way beyond a service provider relationship and enables us to drive high-quality analysis that would otherwise not be possible.”

"The Medidata products are very innovative and support our very complex oncology studies."

“Medidata’s choice to implement the Rave eCOA/ ePRO solution in a unified environment with Rave EDC allows the user to extend their study design knowledge and ease the ePRO design, especially for beginners.“

"We want to use the best in-class technology and we want to combine that with our clinical research."

"Major corporations such as pharmaceutical and medical device manufacturers and institutions such as hospitals and nursing facilities have also committed fraud, sometimes on a grand scale. OIG has a strong record of investigating these corporate and institutional frauds, which often involve complex billing frauds, kickbacks, accounting schemes, illegal marketing and …